Breast Cancer Patients' Cognitive Function: Acupuncture's Surprising Impact
The ENHANCE trial reveals a fascinating insight into the cognitive benefits of acupuncture for breast cancer patients. While the study compared real acupuncture to sham and usual care, the results suggest a more nuanced story.
In the trial, both real acupuncture (RA) and sham acupuncture (SA) led to significant improvements in cognitive function compared to usual care (UC). Patients' subjective cancer-related cognitive dysfunction showed mean increases of 10.3 and 10.5 points for RA and SA, respectively, versus a smaller 4.8-point increase for UC. But here's where it gets interesting: RA outperformed UC at weeks 10 and 26, while SA and RA were not significantly different at these time points.
The Hopkins Verbal Learning Test (HVLT) revealed more insights. RA patients' Total Recall Score improved from baseline, with mean changes of 3.94 and 4.36 at weeks 10 and 26, respectively. UC patients also improved, but SA patients showed a slight decline at week 10, rebounding at week 26. This suggests that while RA offers clear benefits, SA may have a more complex effect on memory.
For patients with objective cognitive impairment, RA again showed the most significant gains in HVLT Delayed Recall Scores. However, SA and UC demonstrated similar improvements at week 10, with SA declining by week 26. This finding raises questions about the mechanisms behind these cognitive improvements.
Dr. Jun J. Mao emphasizes the importance of listening to patients' experiences: "...maybe using a therapeutic approach to listen, validate, care, and provide a process for them to start feeling better..." This statement highlights a potential controversy: Is acupuncture's benefit primarily due to the therapeutic relationship and patient expectations, or are there specific physiological effects at play?
Study participants in the RA group received 10 weekly sessions targeting acupoints for cognition and sleep, while SA and UC groups followed different protocols. Subjective and objective cognitive difficulties were rigorously assessed using standardized tools.
However, the study has limitations. The COVID-19 pandemic may have influenced patient stress and care disruptions. Additionally, the participants' high education levels and specific cancer-related symptoms may limit the generalizability of the findings. The study's single-center design further restricts its applicability to diverse clinical settings.
This research opens a fascinating discussion on acupuncture's role in cancer care. Do these findings support acupuncture as a viable complementary therapy, or do they reveal the power of patient expectations and the therapeutic relationship? The answers may lie in future studies exploring these complex interactions.
